Cardiohemodynamic effects of nitroglycerin and several vasodilators.
D000628:Aminophylline / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003374:Coumarins / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D005260:Female; D006016:Glycolates / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D008297:Male; D009025:Morpholines / Q000494:pharmacology; D009570:Nitriles / Q000494:pharmacology; D005996:Nitroglycerin / Q000494:pharmacology*; D009603:Nitroso Compounds / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D011299:Prenylamine / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology; D014230:Triazoles / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology
D003374:Coumarins; D006016:Glycolates; D009025:Morpholines; D009570:Nitriles; D009603:Nitroso Compounds; D011725:Pyridines; D014230:Triazoles; D014665:Vasodilator Agents; D000628:Aminophylline; D004176:Dipyridamole; D014700:Verapamil; D010208:Papaverine; D005996:Nitroglycerin; D011299:Prenylamine